MedTrace Logo

Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

NCT00673660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 375

Last updated 2021-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to show the compliance rates of the patients to statin treatment and the reasons of non-compliance.

Conditions

Interventions

BEHAVIORAL

Patient Compliance

Compliance of patients to statin treatment and reasons of compliance or non compliance will be obtained by Patient Reported Outcomes (PROs) every 3 months.

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00673660 on ClinicalTrials.gov